Quality standards

It is perhaps this sharp and succinct approach to business that makes Mr D’Amelio the right person to lead Ellman International, as well as play a leading role in the global aesthetic industry.

As the industry itself is continually evolving — and especially in light of regulatory changes throughout Europe that will no doubt impact on a global scale — I was keen to find out what he predicts for the future of our industry.

‘I think the industry as whole  needs to concentrate on more real science and more clinical testing,’ he says. ‘The industry needs high standards, high clinical efficacy and to educate. This is science — medical science — and we take our responsibility to educate our physicians seriously.’

As a company, Ellman International strives to provide this for their customers, ultimately boiling down to the fact that people will buy products through companies and sales representatives they trust.

‘I think that people need to recognise that we are in the medical device industry, and I’m proud of the fact that I started my career as a quality engineer and spent a lot of time as either a VP of quality or regulatory affairs,’ Mr D’Amelio continues.

‘The need to have a robust quality and regulation system, coupled with great engineering and sales, within a company is paramount. I think that’s one of the things a CEO needs to recognise when you’re at the helm of a company like Ellman, which took 50 years of hard work to grow and develop.’

Mr D’Amelio explains that in light of recent events across Europe, it appears that perhaps some companies have lost sight of the higher standards that all should adhere to. There are many who clearly do not have a good enough understanding of what goes into products and their development.

‘If you follow good manufacturing practices and document what you’re doing, understand why you’re doing it, and ensure your products meet the latest standards, then you have the right appreciation for what is needed in this wonderful medical industry.’

Reputation

Talking to Mr D’Amelio, it is clear to see that he is a man passionate about the work he does with Ellman International, and building on the standards required in medical devices — not just with the company he represents, but for the industry as a whole.

‘This is medicine, so first do no harm. As a medical device company we are an extension of the physician’s hands so we have a serious obligation to those physicians to develop products that are worthy, and we have taken 52 years to build that reputation.

‘I want to continue bringing proven products that work clinically, are efficacious and offer good value to physicians within the surgical and aesthetic field.’